There are currently no press releases for this ticker. Please check back later.

Profile

Carmat is medical technology start-up company. The Company intends to market a fully implantable artificial heart for patients suffering in the aftermath of a heart attack or with late-stage heart failure and for whom standard drug therapy, ventricular assistance and/or a heart transplant have failed or are not possible.